BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andrisani G, Guidi L, Papa A, Potenza A, Cervelli D, Armuzzi A. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: Infliximab and surgery. Journal of Crohn's and Colitis 2013;7:421-6. [DOI: 10.1016/j.crohns.2012.07.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Sartini A, Bianchini M, Schepis F, Marzi L, De Maria N, Villa E. Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection. Clin Case Rep 2016;4:195-202. [PMID: 26862424 DOI: 10.1002/ccr3.464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Ben Abdallah H, Fogh K, Bech R. Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review. Int Wound J 2019;16:511-21. [PMID: 30604927 DOI: 10.1111/iwj.13067] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
3 Wcisło-Dziadecka D, Bergler-Czop B, Brzezińska-Wcisło L, Arasiewicz H. Extensive phlegmon and pyoderma gangrenosum: diagnostic difficulties. Postepy Dermatol Alergol 2015;32:46-50. [PMID: 25821427 DOI: 10.5114/pdia.2014.40947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Eisendle K, Thuile T, Deluca J, Pichler M. Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases. Adv Wound Care (New Rochelle) 2020;9:405-25. [PMID: 32320362 DOI: 10.1089/wound.2020.1160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
5 Argüelles-Arias F, Castro-Laria L, Lobatón T, Aguas-Peris M, Rojas-Feria M, Barreiro-de Acosta M, Soto-Escribano P, Calvo-Moya M, Ginard-Vicens D, Chaparro-Sánchez M. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease. Dig Dis Sci. 2013;58:2949-2954. [PMID: 23828140 DOI: 10.1007/s10620-013-2762-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
6 Elbendary A, Kellen R. Off-Label uses of Biologic Agents Approved for Psoriasis and Psoriatic Arthritis for Dermatological Conditions: Part I. Journal of Psoriasis and Psoriatic Arthritis 2016;2:31-7. [DOI: 10.1177/247553031600200105] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Bergler-Czop B, Brzezińska-Wcisło L. Pyoderma gangrenosum in a patient with common variable primary immunodeficiency. Postepy Dermatol Alergol 2013;30:188-91. [PMID: 24278072 DOI: 10.5114/pdia.2013.35622] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
8 Defilippis E, Feldman S, Huang W. The genetics of pyoderma gangrenosum and implications for treatment: a systematic review. Br J Dermatol 2015;172:1487-97. [DOI: 10.1111/bjd.13493] [Cited by in Crossref: 57] [Cited by in F6Publishing: 40] [Article Influence: 8.1] [Reference Citation Analysis]
9 Mckenzie F, Arthur M, Ortega-loayza AG. Pyoderma Gangrenosum: What Do We Know Now? Curr Derm Rep 2018;7:147-57. [DOI: 10.1007/s13671-018-0224-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment. Am J Clin Dermatol. 2017;18:355-372. [PMID: 28224502 DOI: 10.1007/s40257-017-0251-7] [Cited by in Crossref: 98] [Cited by in F6Publishing: 67] [Article Influence: 24.5] [Reference Citation Analysis]
11 McKenzie F, Cash D, Gupta A, Cummings LW, Ortega-Loayza AG. Biologic and small-molecule medications in the management of pyoderma gangrenosum. J Dermatolog Treat 2019;30:264-76. [PMID: 30051737 DOI: 10.1080/09546634.2018.1506083] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
12 Morgenstjerne-Schwenck LET, Knudsen JT, Prasad SC. Efficacy and safety of skin grafting in treatment of vasculitic ulcer and pyoderma gangrenosum-A systematic review. Wound Repair Regen 2021;29:240-53. [PMID: 33377584 DOI: 10.1111/wrr.12882] [Reference Citation Analysis]